You have read all your free articles, to continue reading subscribe to read the rest of this content.
Scandinavian Biopharma has entered into an agreement with the United States Army Medical Research Acquisition Activity (USAMRAA) to support the production and development of the vaccine, with the long-term goal of preventing bacterial diarrhoea in war fighters. In April this year, SBH announced tAlready a subscriber Login You have read…
The company announces that Nasdaq Stockholm decided to halt trading in the company's share as a result of share price movements. Immunicum cannot assess whether these movements are related to information leakage from an ongoing negotiation for a development collaboration. The company therefore wiAlready a subscriber Login You have read…
The Board has initiated this review aiming to optimize shareholder value following its recent decision to discontinue the PARADIGME study for Nordic Nanovector’s lead asset Betalutin and implement a restructuring of the company. The company's Board of Directors has appointed Carnegie InvestmentAlready a subscriber Login You have read all your…
The European Commission has granted conditional marketing authorization (CMA) for CSL's HEMGENIX, the first and only one-time gene therapy for the treatment of severe and moderately severe hemophilia B in adults without a history of Factor IX inhibitors. In the ongoing clinical trial, HEMGENIX rAlready a subscriber Login You have read…
